Clinical Trials Browser

Terminated × cabiralizumab × Clear all

NCT04050462 2025-10-16

Nivolumab Combined With BMS-986253 in HCC Patients

Phase 2 Terminated

13 enrolled 13 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT03599362 2021-10-19

Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer

Phase 2 Terminated

7 enrolled 10 charts

Gastrointestinal

Pancreatic Neoplasms